Feb 14 (Reuters) - Aequus Pharmaceuticals Inc AQS.V :
* Aequus successfully completes dosing in second proof of concept clinical trial of transdermal aripiprazole patch
* Aequus Pharmaceuticals Inc- company expects to report topline results from multi-dose study in Q1 of 2017 for AQS1301 Source text for Eikon: ID:nCCN2zJXkW Further company coverage: AQS.V